Lung Diseases  >>  Zykadia (ceritinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zykadia (ceritinib) / Novartis
NCT01685060 / 2012-003432-24: LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Completed
2
140
Japan, US, Canada, Europe, RoW
LDK378, Ceritinib
Novartis Pharmaceuticals
Non-Small Cell Lung Cancer
03/16
03/16

Download Options